- Home
- ADV vs SWKH Comparison
ADV vs SWKH Comparison
Compare ADV & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADV | SWKH |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | 69000 | 9 |
| Industry | Business Services | Diversified Financial Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.6M | 198.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ADV | SWKH |
|---|---|---|
| Price | $28.86 | $16.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $45.83 | $18.00 |
| AVG Volume (30 Days) | ★ 472.2K | 18.8K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.63 | N/A |
| Revenue Next Year | $0.45 | N/A |
| P/E Ratio | ★ N/A | $9.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $13.00 |
| 52 Week High | $30.00 | $18.40 |
Technical Indicators
Market Signals| Indicator | ADV | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 77.91 | 32.19 |
| Support Level | $1.00 | $14.69 |
| Resistance Level | N/A | $17.08 |
| Average True Range (ATR) | 3.00 | 0.37 |
| MACD | 0.86 | -0.05 |
| Stochastic Oscillator | 95.48 | 12.06 |
Price Performance
Historical ComparisonAbout ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.